Header Logo

Connection

Christopher Aston to Risk Factors

Back to Details
This is a "connection" page, showing publications Christopher Aston has written about Risk Factors.
Christopher Aston
Connection Strength
0.408
Risk Factors
  1. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol. 1999 Nov; 17(4):253-73.
    View in: PubMed
    Score: 0.028
  2. Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development. J Urol. 2019 11; 202(5):1046-1051.
    View in: PubMed
    Score: 0.027
  3. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
    View in: PubMed
    Score: 0.027
  4. Obesogenic Behaviors and Depressive Symptoms' Influence on Cardiometabolic Risk Factors in American Indian Children. J Allied Health. 2019; 48(2):100-107.
    View in: PubMed
    Score: 0.026
  5. Who, where, and why are patients lost to follow-up? A 20-year study of bladder exstrophy patients at a single institution. J Pediatr Urol. 2018 06; 14(3):276.e1-276.e6.
    View in: PubMed
    Score: 0.025
  6. Vitamin D Status, Gender Differences, and Cardiometabolic Health Disparities. Ann Nutr Metab. 2017; 70(2):79-87.
    View in: PubMed
    Score: 0.023
  7. Choroid plexus cysts and trisomy 18: risk modification based on maternal age and multiple-marker screening. Am J Obstet Gynecol. 1996 Dec; 175(6):1493-7.
    View in: PubMed
    Score: 0.023
  8. Mortality benefit of statin use in traumatic spinal cord injury: a retrospective analysis. Spinal Cord. 2016 Apr; 54(4):298-302.
    View in: PubMed
    Score: 0.021
  9. Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 1995 Sep; 117(1):73-81.
    View in: PubMed
    Score: 0.021
  10. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population. J Diabetes Complications. 2015 Nov-Dec; 29(8):1191-7.
    View in: PubMed
    Score: 0.021
  11. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers. J Diabetes Complications. 2015 Jul; 29(5):679-85.
    View in: PubMed
    Score: 0.020
  12. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. J Thromb Haemost. 2012 May; 10(5):833-9.
    View in: PubMed
    Score: 0.016
  13. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort. Pharmacogenet Genomics. 2012 Feb; 22(2):95-104.
    View in: PubMed
    Score: 0.016
  14. A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: genetic risk is modulated by obesity. Nutr Metab Cardiovasc Dis. 2012 Nov; 22(11):944-51.
    View in: PubMed
    Score: 0.015
  15. Investigating genomic imprinting and susceptibility to insulin-dependent diabetes mellitus: an epidemiologic approach. Genet Epidemiol. 1991; 8(3):177-86.
    View in: PubMed
    Score: 0.015
  16. Segregation analysis of alcoholism in families ascertained through a pair of male alcoholics. Am J Hum Genet. 1990 May; 46(5):879-87.
    View in: PubMed
    Score: 0.014
  17. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet. 2000 Sep; 107(3):257-67.
    View in: PubMed
    Score: 0.007
  18. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett. 1999 Mar 26; 263(2-3):129-32.
    View in: PubMed
    Score: 0.007
  19. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet. 1998 Jan; 62(1):36-44.
    View in: PubMed
    Score: 0.006
  20. Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations in normoglycemic Hispanics and non-Hispanic whites from the San Luis Valley, Colorado. Am J Epidemiol. 1997 Dec 15; 146(12):1011-8.
    View in: PubMed
    Score: 0.006
  21. A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus. Atherosclerosis. 1997 Jul 25; 132(2):221-7.
    View in: PubMed
    Score: 0.006
  22. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 1997 Jun; 17(6):1067-73.
    View in: PubMed
    Score: 0.006
  23. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol. 1997; 14(2):169-80.
    View in: PubMed
    Score: 0.006
  24. Genetic analysis of families with nonsmoking lung cancer probands. Genet Epidemiol. 1997; 14(2):181-97.
    View in: PubMed
    Score: 0.006
  25. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. Ann N Y Acad Sci. 1996 Dec 16; 802:27-34.
    View in: PubMed
    Score: 0.006
  26. Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls. Atherosclerosis. 1996 Sep 27; 126(1):35-42.
    View in: PubMed
    Score: 0.006
  27. Race, socioeconomic status, and obesity in 9- to 10-year-old girls: the NHLBI Growth and Health Study. Ann Epidemiol. 1996 Jul; 6(4):266-75.
    View in: PubMed
    Score: 0.005
  28. Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet. 1995 Jul; 57(1):150-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.